SEC Form 4 · accession 0001062993-15-002134
BIOSPECIFICS TECHNOLOGIES CORP · BSTC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Jennifer M Chao
Director
Period of report
Apr 22, 2015
Accepted (ET)
Apr 22, 2015 · 9:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875622
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $37.93 | Apr 22, 2015 | A | 15,000 | A | — | Apr 22, 2025 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1The options were granted on April 22, 2015 and will vest in four equal annual installments beginning on the first anniversary of the grant date.